LENALIDOMIDE AND RITUXIMAB (ReRi) AS FRONT LINE THERAPY OF ELDERLY FRAIL PATIENTS WITH DIFFUSE LARGE B‐CELLS LYMPHOMA. FIRST PLANNED INTERIM ANALYSIS OF A PHASE II STUDY OF THE FONDAZIONE ITALIANA LINFOMI (FIL). (12th June 2019) - Gini, G.; Tani, M.; Bassan, R.; Tucci, A.; Ballerini, F.; Sampaolo, M.; Merli, F.; Re, F.; Annibali, O.; Liberati, A.; Visco, C.; Arcari, A.; et al.